Skip to main content
Clinical Trials/NCT07337473
NCT07337473
Not yet recruiting
Not Applicable

Effect of Evidence-based Digital Cognitive Behavior Therapy for Adolescents With Nonsuicidal Self-Injury Disorder: A Randomized Clinical Trial

Peking University Sixth Hospital0 sites100 target enrollmentStarted: January 31, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Peking University Sixth Hospital
Enrollment
100
Primary Endpoint
Ottawa Self-injury Inventory(OSI)

Overview

Brief Summary

To evaluate if evidence-based digital cognitive behaviour therapy for adolescents is an efficacious treatment when delivered as an adjunctive treatment to treatment as usual, compared to a control group consisting of treatment as usual.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
12 Years to 25 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 5 nonsuicidal self-injury episodes past year
  • 1 nonsuicidal self-injury episodes past month having at least one parent who committed to participate in the program

Exclusion Criteria

  • Severe suicidal ideation a diagnosis of psychotic or ongoing (past month) substance dependence the presence of co-occurring psychological disorders that required immediate treatment (i.e., severe anorexia nervosa)

Arms & Interventions

Evidence-based digital CBT group

Experimental

Participants will receive 6 weeks of evidence-based digital cognitive behaviour therapy, adjunctive to treatment as usual, as provided in the community or research group.

Intervention: Evidence-based digital cognitive behaviour therapy (Behavioral)

Health Education group

Active Comparator

Participants will receive health education for 6 weeks, adjunctive to treatment as usual, as provided in the community or research group.

Intervention: Health Education (Behavioral)

Outcomes

Primary Outcomes

Ottawa Self-injury Inventory(OSI)

Time Frame: From the date of baseline assessment (enrollment) until the date of 12-month follow-up, assessed at baseline, post-treatment (Day 1 of the week following treatment completion), and 1 month, 6 months, and 12 months after post-treatment.

Assessing the frequency and severity of nonsuicidal self-injury

Secondary Outcomes

  • General Anxiety Disorder-7(Change from baseline (Day 1 of study enrollment), assessed every 2 weeks during the 6-week treatment period, at post-treatment (Day 1 of the week following treatment completion), and at 1 month, 6 months, and 12 months after post-treatment.)
  • Beck's Suicide Intent Scale(Change from baseline (Day 1 of study enrollment), assessed every week during the 6-week treatment period, at post-treatment (Day 1 of the week following treatment completion), and at 1 month, 6 months, and 12 months after post-treatment.)
  • Self-harm behaviour craving visual analog scale(Change from baseline (Day 1 of study enrollment), assessed every week during the 6-week treatment period, at post-treatment (Day 1 of the week following treatment completion), and at 1 month, 6 months, and 12 months after post-treatment.)
  • Difficulties in Emotion Regulation Scale - 16-item version (DERS)(Change from baseline (Day 1 of study enrollment), assessed at post-treatment (Day 1 of the week following treatment completion), and at 1 month, 6 months, and 12 months after post-treatment.)
  • Patient Health Questionnaire-9(Change from baseline (Day 1 of study enrollment), assessed every 2 weeks during the 6-week treatment period, at post-treatment (Day 1 of the week following treatment completion), and at 1 month, 6 months, and 12 months after post-treatment.)

Investigators

Sponsor
Peking University Sixth Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yi Zhong

Peking University

Peking University Sixth Hospital

Similar Trials